SpringWorks Therapeutics (SWTX) Reports Q4 Loss, Tops Revenue Estimates

SpringWorks Therapeutics (SWTX) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of$ 0.72. This compares to loss of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -44.44%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.76 per share when it actually produced a loss of $0.72, delivering a surprise of 5.26%.Over the last four quarter ...